Fritextsökning
Innehållstyper
-
“You discover one thing – and then 10 new questions arise”
COVID-19, diabetes, heart disease, and the impact of dog ownership on humans are just some of multitasker Tove Fall’s areas of research. However, her current fo...
-
Ossiform: Quality control of 3D printed bone implants
Ossiform chose the GOM Scan 1.
-
Behöver du vätskekylning under noll grader?
SMC erbjuder cirkulationskylare för en rad olika appikationer och temperaturer, minusgrader inkluderat. Kontakta oss så hittar vi rätt lösning för dig!
-
From Valneva to the CEO position at NorthX – “I saw it as a great opportunity”
A new cell therapy for leukaemia, a vaccine in tablet form against cholera, and a proprietary mRNA line with the potential capacity to supply the entire Nordic ...
-
It couldn’t be simpler
AI-assisted ZEISS Solution inspects implant coatings automatically.
-
ZEISS presents the "Quality Innovation Days"
The digital event for metrology and software.
-
Läkemedel slipper Trumps tullar – branschens reaktioner
USA inför tullar på minst 10 procent på i stort sett alla importerade varor. Men läkemedel undantas, enligt det senaste budet. Branschorganisationer betonar vik...
-
A new giant among our microscopes
Two technologies in one machine.
-
”Information security must become part of the Swedish life science strategy”
Sweden needs knowledge security to stand strong in the global competition, writes Björn Ursing in an opinion article.
-
Ingrid Lönnstedt: Demystification of the power of a scientific study
”You surely do realize that even the smallest changes in study assumptions may influence the estimated sample size needed. And how is it even possible to guess ...
-
Enabling 3D Multiplexing Spatial Omics Workflows in Neuroscience
Case study by ZEISS Microscopy.
-
Lundbeck kliver in i budstrid om narkolepsibolag
En budstrid har brutit ut om det irländska biotechbolaget Avadel Pharmaceuticals och dess potentiella storsäljare inom narkolepsi och hypersomni.
-
Samuel Lagercrantz: ”Will the Swedish life science strategy be updated with precision?”
What will the Swedish government focus on in the life science strategy that is being updated? And what should be prioritized in the strategy? Life Science Swede...
-
Study: Popular diabetes drug may be effective against liver disease
After its success in diabetes and weight loss, a new potential therapeutic area has been identified for Ozempic and other GLP1 analogues. A new study links the ...
-
A mass flow controller that is silent, fast and cost-effective
Portable ventilator breathing devices, bioreactors or the dosing of inert gases all rely on the highest control dynamics. That is exactly what the proportional ...
-
Standardisation in automation
B. Braun Melsungen had a great idea and implemented it throughout the plant. Production for infusion solutions was to be largely standardised. B. Braun hoped th...
-
No longer afraid of the dentist.
Teaching robot with piezo technology
-
AstraZeneca moves to brewery quarters in central Copenhagen
AstraZeneca in Denmark is moving its business into central Copenhagen and the old brewery quarters in Carlsberg Byen.
-
ZEISS Insights: Measurement of bone plates and screws
Get free access to technical paper.
-
The International Vaccine Institute’s office in Sweden is expanding
The International Vaccine Institute’s Stockholm office has been open for over a year. During the past year, training programmes and projects have been launched,...
-
Major investment in women’s health – for a more equal healthcare system
”The regional differences need to decrease and the long-term supply of midwives and other professions needs to be secured,” write Acko Ankarberg Johansson and D...
-
Medical device quality assurance
Recordings from ZEISS Quality Innovation Days.
-
Domare stoppar J & J:s 100 miljardersuppgörelse om babypuder
En amerikansk konkursdomare har avvisat Johnson & Johnsons erbjudande på 10 miljarder dollar, motsvarande 100 miljarder kronor, för att få slut på den rättsliga...
-
Eli Lilly to build a USD 2.5-billion plant in Germany
US-based Eli Lilly is planning a huge investment of USD 2.5 billion, equivalent to around SEK 26.5 billion, in a new production facility in Alzey, Germany.